Cargando…
Letter: studies of salivary pepsin in patients with gastro‐oesophageal reflux disease
Linked Content This article is linked to Race et al and Corfe et al papers. To view these articles, visit https://doi.org/10.1111/apt.15138 and https://doi.org/10.1111/apt.15225.
Autores principales: | Dettmar, Peter William, Woodcock, Andrew David, Wilcox, Matthew David, Chater, Peter Ian, Pearson, Jeffrey Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6667995/ https://www.ncbi.nlm.nih.gov/pubmed/30977170 http://dx.doi.org/10.1111/apt.15213 |
Ejemplares similares
-
Reflux Revisited: Advancing the Role of Pepsin
por: Bardhan, Karna Dev, et al.
Publicado: (2012) -
Can We Apply the Salivary Pepsin Test for Patients With Gastroesophageal Reflux Disease in Primary Practice?
por: Lee, Tae Hee
Publicado: (2020) -
Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders
por: Wang, Yan-Jun, et al.
Publicado: (2020) -
Validation in China of a non‐invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease
por: Wang, Yong Feng, et al.
Publicado: (2019) -
Gastro-oesophageal reflux disease and eosinophilic oesophagitis: What is the relationship?
por: Wong, Stephanie, et al.
Publicado: (2018)